drugset / Trial / NCT07533955
A Phase 1 Study of JADE201 in Participants With Rheumatoid Arthritis
RandomizedSequentialDouble-blindBasic science
Summary
This is a Phase 1, first in human study to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of single ascending doses of JADE201 compared to placebo in participants with Rheumatoid Arthritis
Timeline
- Start
- 2026-05-19
- Primary completion
- 2027-10
- Completion
- 2028-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | JADE201 | Unknown | — | Subcutaneous |